FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387032003: Lipase preparation (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2003. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1461210014 Lipase preparation (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1481146017 Lipase preparation en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Lipase preparation Is a Lipase false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing triacylglycerol lipase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 16600unt/5000unt/18750unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 20000unt/4500unt/25000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 20000unt/5000unt/20000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 25000unt/4000unt/25000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 30000unt/10000unt/30000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 30000unt/8000unt/30000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 30000unt/8000unt/30000unt tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 3000unt/2400unt/3000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 33200unt/10000unt/37500unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 39000unt/12000unt/39000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 40000unt/8000unt/45000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 48000unt/16000unt/48000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 56000unt/20000unt/44000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 58500unt/18000unt/58500unt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 58500unt/18000unt/58500unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 6000unt/16000unt/6000unt tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 65000unt/20000unt/65000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 66400unt/20000unt/75000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 664400unt/20000unt/75000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 70000unt/16800unt/70000unt powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 8000unt/30000unt/30000unt tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some
    Amylase + lipase + protease 12000unt/4000unt/12000unt capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Lipase preparation Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    SAME AS association reference set (foundation metadata concept)

    Back to Start